✨ Your Portfolio is fetched and updated from zerodha.
Small CDMO

Acutaas Chemicals Ltd.

ACUTAAS

Market Cap
₹25,688 Cr.
P/E
72.11

Acutaas Chemicals Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
25,688 Cr
PE
PE
72.11
Prom Holding
Prom Holding
32.66 %
ROE (%)
ROE (%)
12.12
ROCE (%)
ROCE (%)
16.51
Div Yield (%)
Div Yield (%)
0.08
Sales
Sales
1,339 Cr
OPM (%)
OPM (%)
35.87 %
Debt to Equity
Debt to Equity
0.01
Institutions
Institutions
39.09 %
Individual < 2 lac
Individual < 2 lac
14.81 %
No. of Shareholders
No. of Shareholders
1.13 L
View more
Edit Ratio's

About

Acutaas Chemicals Ltd. is a research-driven specialty chemicals manufacturer focused on advanc… Read more
Low
1059
52W Range
High
3180
  • Acutaas Chemicals
  • Supriya Lifescience
  • Aether Industries
  • TJI Pharma - API & CRAMS

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

9 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

50 %
(as of Mar 21)
Source/Historic
4-Dihydroxy 5 Nitrobenzaldehyde - Market Share
40 %
(as of Mar 21)
Source/Historic
6-Methoxy Carbonyl-2-Oxindole-Fg Market Share
88 %
(as of Mar 21)
Source/Historic
Dichloropyrimidine Market Share
60 %
(as of Mar 21)
Source/Historic
Glycidyl Phthalimide Market Share
75 %
(as of Mar 21)
Source/Historic
Intermediate - Amino Acetaldehyde Dimethyl Acetal - Global Market Share
45 %
(as of Mar 21)
Source/Historic
Morpholin-3-One Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Verticals

Therapeutic Area Break-Up

Acute vs Chronic

Asset Break-Up - Segment Wise

API Break-Up

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on Acutaas Chemicals Ltd. Business

Acutaas Chemicals Ltd. is a research-driven specialty chemicals manufacturer focused on advanced pharmaceutical intermediates, CDMO services, battery chemicals, semiconductor materials, and specialty chemicals for global pharma, agrochemical, and industrial applications.

Acutaas Chemicals major competitors are Supriya Lifescience, Aether Industries, Neuland Laboratories, Granules India, Alivus Life Sciences, Shilpa Medicare.
Market Cap of Acutaas Chemicals is ₹25,688 Crs.
While the median market cap of its peers are ₹13,761 Crs.

Acutaas Chemicals seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Jan May Jul Oct Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Sep
Investor Presentation Jan Apr May May Jul Oct Mar May Jun Sep Dec Mar Jun Sep Dec Feb Mar May Jun Aug Sep Dec Sep Dec
Conference Call Feb May Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec
Conference Call SummaryCon Call Summary

Discussions & Analysis

Acutaas Chemicals Ltd.
Deep Dive Into Ami Organics - Value Educator
AMI Organics - A Small Cap Stock in Super Investor Portfolios - SOIC
Why We Bought Ami Organics - Marcellus
DHANDHA: Ami Organics Ltd - PART 2 | Let's Talk Business - Omkara Capital
Deep Dive With Executive Chairman & MD, Naresh Patel - CNBC
View the discussion on ValuePickr
Ami Organics Ltd - Discussion with Management - Omkara Capital
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material